Darren Mooney
@Pfm Health Sciences, Lp
Latest period2024 - Q3ReportedManaged Assets$1.765BTotal holdings74
Assets growth rate-12.66%Assets growth rate (2-Q avg)-8.83%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Pfm Health Sciences, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 74 positions.
Assets under management
The assets under management (AUM) of Pfm Health Sciences, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.765B in assets, with a quarterly growth rate of -12.66% and a 2-quarter average growth rate of -8.83%. The portfolio is managed by Darren Mooney, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ACHCAcadia Healthcare Company In
| 2.47% | $43.509M 686,150 shares@ $63.42 avg price | Increased 63.31% |
ELVElevance Health Inc
| 1.67% | $29.349M 56,441 shares@ $520.0 avg price | Increased 2.16% |
AMGNAmgen Inc
| 1.65% | $29.095M 90,297 shares@ $322.21 avg price | Increased 11.44% |
0435⤦Ascendis Pharma A S
| 1.52% | $26.815M 23M shares@ $1.17 avg price | Increased 27.78% |
WATWaters Corp
| 1.05% | $18.377M 51,063 shares@ $359.89 avg price | Increased 148.6% |
ERASErasca Inc
| 0.76% | $13.314M 4.877M shares@ $2.73 avg price | Increased 4.4% |
CRBUCaribou Biosciences Inc
| 0.48% | $8.441M 4.307M shares@ $1.96 avg price | Increased 5.47% |
SNDXSyndax Pharmaceuticals Inc
| 0.47% | $8.16M 423,910 shares@ $19.26 avg price | Increased 9.44% |
HOWLWerewolf Therapeutics Inc
| 0.41% | $7.205M 3.399M shares@ $2.13 avg price | Increased 4.87% |
XENEXenon Pharmaceuticals Inc
| 0.41% | $7.082M 179,878 shares@ $39.38 avg price | Increased 19.48% |